MPCC calls for cortisol monitoring during Tour de France

The doping control van is hard to miss.

The doping control van is hard to miss. (Image credit: www.ispaphoto.com)

The Movement for Credible Cycling (MPCC) has made a request to the French Anti-Doping Agency (AFLD) that cortisol levels also be monitored during the Tour de France this year.

Teams signing on to the MPCC charter agree not to field riders while they hold a therapeutic use exemption (TUE) for cortisone and they agree to undergo four voluntary tests for cortisol levels throughout the season. At present, BMC, Cannondale, Euskaltel Euskadi, Movistar, Omega Pharma-Quick-Step, RadioShack Leopard, Saxo-Tinkoff and Sky are all non-signatories to the MPCC.

According to L'Equipe, the letter sent to French Sports Minister Valerie Fourneyron, says that: "It would make sense that the 22 teams are controlled in the same way and medically monitored externally."

The AFLD will be carrying out additional testing at this year's Tour after an agreement was reached with the UCI allowing whereabouts information on riders and biological passport data to be shared so that the AFLD can perform random tests.

Cortisone is permitted by the World Anti-Doping Agency if an athlete carries a TUE. 

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1